Propionate metabolism dysregulation promotes drug-tolerant persister cell survival in non-small cell lung cancer
Bobak Parang, Liron Yoffe, Rabia Khan, Zhongchi Li, Michal J. Nagiec, Eric E. Gardner, Yiwey Shieh, Rachel S. Heise, Ashish Saxena, Nasser Khaled Altorki, John Blenis
This study shows that propionate metabolism dysregulation, through MMA accumulation and EMT activation, promotes drug-tolerant persister cell survival in NSCLC.
bioRxiv · Oct 15, 2025 · PreprintCancer Biology